No Collaboration between Jingjia Stock and Huada Beidou

Business by 2FIRSTS.ai
Dec.14.2023
No Collaboration between Jingjia Stock and Huada Beidou
Investors asked Jinyan Corporation whether they planned to collaborate with Huada Beidou in the development of satellite communication e-cigarettes.

On December 14th, an investor raised a question on an investor interactive platform to Jingjia Corporation, asking whether the company, being a shareholder of Huada Beidou, intends to collaborate with them to develop an e-cigarette that utilizes satellite communication technology.

No Collaboration between Jingjia Stock and Huada Beidou
Image source: Interactive Easy

 

Jinjia Corporation (stock code: 002191.SZ) responded by stating that there is no partnership between Huada Beidou and the company in the field of new tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Observations | Two Months After Launch, BAT’s VELO Shift Draws Attention for Non-Traditional Design as Some Users Call for Higher Nicotine Strength
2Firsts Observations | Two Months After Launch, BAT’s VELO Shift Draws Attention for Non-Traditional Design as Some Users Call for Higher Nicotine Strength
British American Tobacco (BAT) introduced the VELO Shift nicotine pouch in September 2025, featuring a hexagonal outer can and an oval-triangle pouch shape that departs from traditional designs. Two months after launch, the product is available in the U.K., U.S. and Sweden. Social-media feedback indicates the design has been well received, while some users are calling for higher nicotine strength.
Nov.06 by 2FIRSTS.ai
Philip Morris International Restructures to Drive Its Smoke-Free Transformation
Philip Morris International Restructures to Drive Its Smoke-Free Transformation
Philip Morris International (PMI) announced a new organizational model effective January 1, 2026, creating two main business units — PMI International and PMI U.S. — to accelerate its smoke-free strategy. The restructuring replaces four regional segments with three: International Smoke-Free, International Combustibles, and U.S., enhancing agility, governance, and long-term growth in reduced-risk products.
Nov.05 by 2FIRSTS.ai
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgian Drug Commissioner Warns of Hidden Opioids in Illegal Vapes
Belgium’s drug commissioner Ine Van Wymersch has warned that more than 80% of illegal refillable vape capsules seized in Belgium contain synthetic opioids, posing serious risks of early addiction among children. She told Euronews that these substances, which have no distinctive smell or color, could lead to opioid dependence from a young age.
Dec.08 by 2FIRSTS.ai
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory
The High Court in Bangladesh has asked government bodies to explain why the approval granted to Philip Morris to establish a nicotine pouch factory should not be deemed illegal. Petitioners argue the decision contradicts existing policies and a 2016 Appellate Division ruling that restricts new tobacco-related enterprises. Authorities have ten days to respond.
Nov.20 by 2FIRSTS.ai
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma May Soon Consider Full Ban on Vape Sales
Russia’s State Duma will soon consider a proposal to impose a complete ban on the sale of vapes. The move follows President Vladimir Putin’s endorsement of a nationwide prohibition. Lawmaker Aleksey Volotskov said vape use has surged by 52% since early 2025, with illegal products now dominating 80% of the market.
Nov.11 by 2FIRSTS.ai
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.
Nov.03